Mitesco (MITI) Gains from Sales and Divestitures (2017 - 2020)
Mitesco (MITI) reported Gains from Sales and Divestitures of $1.0 million for Q3 2020, little changed on a QoQ basis from $1.0 million in Q2 2020.
Mitesco (MITI) has 2 years of Gains from Sales and Divestitures data on file, last reported at $1.0 million in Q3 2020.
- Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $1.0 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $1.0 million (changed N/A YoY) and the FY2024 annual result came in at $869690.0, changed N/A from the prior year.
- Gains from Sales and Divestitures was little changed at $1.0 million in Q3 2020 per MITI's latest filing, from $1.0 million in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $1.0 million in Q2 2020 and bottomed at $100000.0 in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Mitesco | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 250,000.00 |
| Sep 30, 2020 | 250,000.00 |
| Jun 30, 2020 | 1.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Mar 31, 2017 | 100,000.00 |
| Mar 31, 2017 | 100,000.00 |